{"gene":"DCHS1","run_date":"2026-06-09T23:54:41","timeline":{"discoveries":[{"year":2011,"finding":"DCHS1 and FAT4 function as a ligand-receptor pair during mammalian development; mutation of either gene increases protein staining for the other, and single and double mutants share similar phenotypes across multiple organs, establishing their epistatic relationship.","method":"Gene-targeted mouse mutants (Dchs1 and Fat4 single and double knockouts), immunostaining, phenotypic analysis across multiple organs","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic interaction confirmed by double mutants and protein-level stabilization; replicated across multiple organs and tissues in a single rigorous study","pmids":["21303848"],"is_preprint":false},{"year":2013,"finding":"DCHS1 and FAT4 act upstream of YAP (a transcriptional effector of the Hippo signaling pathway) to regulate neural progenitor proliferation and differentiation; concurrent knockdown of Yap countered the increased progenitor numbers caused by Dchs1 or Fat4 knockdown in mouse neuroepithelium.","method":"In utero knockdown in mouse embryonic neuroepithelium, genetic epistasis (Yap concurrent knockdown), histological analysis of cortical layering","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with Yap rescue, replicated across DCHS1 and FAT4, multiple orthogonal methods","pmids":["24056717"],"is_preprint":false},{"year":2014,"finding":"DCHS1 and FAT4 are expressed in complementary gradients and are required cell-autonomously within facial branchiomotor (FBM) neurons and extrinsically within the neuroepithelium for collective tangential neuronal migration and planar cell polarity; Fat-PCP and Fz-PCP regulate FBM neuron migration along orthogonal axes.","method":"Mouse conditional knockouts, mosaic inactivation of Dchs1, live imaging of neuronal migration, planar cell polarity analysis","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic mosaic and conditional KO experiments, multiple orthogonal methods, cell-autonomous and non-autonomous roles distinguished","pmids":["24998526"],"is_preprint":false},{"year":2015,"finding":"DCHS1 missense mutations reduce protein stability in zebrafish, cultured cells, and human mitral valve interstitial cells (MVICs); DCHS1-deficient MVICs show altered migration and cellular patterning, and Dchs1+/- mice exhibit mitral valve prolapse traceable to developmental valve morphogenesis errors.","method":"Zebrafish morpholino knockdown with mRNA rescue, protein stability assays in cultured cells and patient-derived MVICs, Dchs1+/- mouse histology, cell migration assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (zebrafish rescue, patient cells, mouse model), functional rescue demonstrates causality of mutation","pmids":["26258302"],"is_preprint":false},{"year":2015,"finding":"FAT4 acts non-autonomously in the renal stroma to bind DCHS1/DCHS2 in the cap mesenchyme and restrict nephron progenitor self-renewal; FAT4-dependent regulation of cap mesenchyme is independent of YAP, and DCHS1 and its paralogue DCHS2 function in a partially redundant manner.","method":"Tissue-specific conditional deletions (stromal Fat4 KO), genetic double mutants (Six2-/-;Fat4-/-), electron microscopy, gene expression analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific KO, double-mutant epistasis, multiple orthogonal methods in one study","pmids":["26116661"],"is_preprint":false},{"year":2015,"finding":"DCHS1 protein localizes in a polarized manner within cap mesenchyme cells, accumulating at the interface with stromal cells, and is required specifically within cap mesenchyme for Fat4-dependent stroma-to-cap mesenchyme signaling during kidney development.","method":"Antibody staining of genetic mosaics, conditional Dchs1 KO, immunolocalization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — mosaic analysis, conditional KO, direct polarized protein localization with functional consequence established","pmids":["26116666"],"is_preprint":false},{"year":2016,"finding":"The Dchs1-Fat4 planar cell polarity pathway controls cell orientation in pre-chondrogenic mesenchyme to define skeletal shape; loss of Dchs1 or Fat4 disrupts polarized cell intercalation driving sternum morphogenesis, establishing intrinsic PCP function of Dchs1-Fat4 in mesenchyme.","method":"Dchs1 and Fat4 mouse knockouts, cell orientation analysis, histological and morphometric analysis of sternum","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — KO mouse phenotype with quantified cell polarity analysis, single lab but multiple methods","pmids":["27145737"],"is_preprint":false},{"year":2016,"finding":"Fat4-Dchs1 regulates cell proliferation in developing vertebrae independently of Yap and Taz; Fat4 and Dchs1 mutant mice show decreased proliferation in early sclerotome, and Fat4;Yap and Fat4;Taz double mutants do not rescue the vertebral phenotype.","method":"Fat4 and Dchs1 knockout mice, Fat4;Yap and Fat4;Taz double mutants, proliferation assays, Ctgf expression analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with Yap and Taz double mutants, multiple orthogonal methods, negative result for Hippo pathway involvement rigorously established","pmids":["27381226"],"is_preprint":false},{"year":2019,"finding":"Dchs1-Fat4 signaling is required for osteoblast differentiation; loss of Dchs1-Fat4 increases Yap-Tead activity and osteoprogenitor proliferation while delaying osteoblast differentiation; Yap and Taz differentially regulate Runx2 transcriptional activity, and Yap-Runx2 and Taz-Runx2 complex activities are altered in Dchs1/Fat4 mutants.","method":"Dchs1 and Fat4 mouse knockouts, Yap/Taz conditional knockouts, Yap-Tead reporter assays, Runx2 transcriptional activity assays, co-immunoprecipitation of Yap/Taz-Runx2 complexes","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — Co-IP for complexes, reporter assays, conditional KO epistasis, single lab with multiple orthogonal methods","pmids":["31358536"],"is_preprint":false},{"year":2022,"finding":"DCHS1 interacts with cytoplasmic protein LIX1L (Lix1-Like) and SEPT9; this DCHS1-LIX1L-SEPT9 axis promotes filamentous actin organization to direct cell-ECM alignment and valve tissue shape.","method":"Biochemical co-immunoprecipitation/pulldown, mouse and cell culture models, actin organization assays","journal":"Journal of cardiovascular development and disease","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP for novel protein interactions, functional phenotype in cells and mouse, single lab","pmids":["35200715"],"is_preprint":false},{"year":2025,"finding":"The intracellular domain (ICD) of Fat4 controls trans-endocytosis of Dchs1 into Fat4 cells and boundary accumulation of Fat4/Dchs1 complexes; removing the Fat4 ICD reduces both Dchs1 trans-endocytosis and boundary accumulation but does not affect diffusion of complexes at the boundary; actin polymerization is required for boundary accumulation of Fat4/Dchs1 complexes.","method":"Quantitative live imaging, ICD deletion constructs, actin polymerization inhibition","journal":"Biophysical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative live imaging with deletion mutants, single lab, single study","pmids":["39955614"],"is_preprint":false},{"year":2025,"finding":"DCHS1 undergoes proteolytic cleavage generating intracellular C-terminal fragments; cardiac DCHS1 expression is restricted to non-cardiomyocyte lineages, displays dynamic subcellular localization during development, and DCHS1-positive non-myocyte cells form polarized extensions bridging endothelial and non-myocyte cells, suggesting direct heterotypic and homotypic interactions.","method":"Dchs1-HA knock-in mouse, immunohistochemistry, western blotting, single-cell transcriptomics","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — direct localization with HA knock-in model, western blot evidence for cleavage, single lab multiple methods","pmids":["40497950"],"is_preprint":false},{"year":2025,"finding":"Phosphorylation of Cx43 at serine 282 increases DCHS1 gene expression, which activates YAP phosphorylation and inhibits the YAP/TEAD signaling pathway to suppress cardiac fibrosis.","method":"Lentiviral overexpression and mutation of Cx43 S282 in cardiac myofibroblasts, mRNA sequencing/GSEA, in vivo adenoviral injection, Hippo pathway reporter assays","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, DCHS1 as intermediate in Cx43-YAP axis supported mainly by expression changes and pathway inference, limited direct mechanistic validation of DCHS1's role","pmids":["39938686"],"is_preprint":false},{"year":2025,"finding":"A modern human-specific substitution in DCHS1 disrupts an N-glycosylation site; restoring the ancestral (Neanderthal) DCHS1 variant in human iPSC-derived neural organoids expands striatal progenitors at the expense of neocortex. EPHA4 (ephrin receptor) was identified as a binding partner of DCHS1, and DCHS1 modulates EPHA4-ephrin signaling.","method":"CRISPR/Cas9 editing of hiPSCs, neural organoids, binding partner identification (method not fully specified in abstract)","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, binding partner not validated by reciprocal or in vitro assay as described in abstract, single lab","pmids":["40463223"],"is_preprint":true},{"year":2026,"finding":"Deletion of the DCHS1 intracellular domain (ICD) in mice results in loss of polarized DCHS1 localization in the subventricular zone, altered neural cell polarization, increased Ki67+ proliferation with greater Ki67-neuronal co-localization, and reduced pYAP1:YAP1 ratios in neonatal brains; craniofacial and skeletal phenotypes resembling Van Maldergem Syndrome are also observed.","method":"Dchs1Δ (ICD deletion) knock-in mouse, immunohistochemistry, western blotting, Ki67 proliferation assays, pYAP1 quantification","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ICD deletion KI mouse with multiple phenotypic readouts and Hippo pathway quantification, single lab","pmids":["41972678"],"is_preprint":false},{"year":2024,"finding":"In DCHS1 patient-derived neurons (from individuals with periventricular heterotopia), patch-clamp recordings revealed a decreased spike threshold due to increased somatic voltage-gated sodium channels; morphological rescue was observed by re-expression of wild-type DCHS1.","method":"Human cerebral organoids from FAT4/DCHS1 mutation carriers, silicon probe recordings, patch-clamp electrophysiology, morphological reconstruction, immunostaining, transcriptome/proteome analysis, DCHS1 rescue experiment","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patch-clamp with rescue experiment in organoids, single lab, preprint","pmids":[],"is_preprint":true},{"year":2024,"finding":"TFPI-2 promotes high-calcium-induced calcification of renal interstitial fibroblasts via upregulation of DCHS1, which in turn disturbs the balance of ENPP1/ALP activities; DCHS1 knockdown suppressed TFPI-2-enhanced calcification.","method":"Transcriptome sequencing, TFPI-2 knockdown/overexpression, DCHS1 knockdown in human renal interstitial fibroblasts, Alizarin Red staining, ENPP1/ALP activity assays","journal":"Urolithiasis","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, downstream pathway placement of DCHS1 in a non-canonical context based on knockdown only","pmids":["39196305"],"is_preprint":false}],"current_model":"DCHS1 is a large transmembrane protocadherin that forms heterophilic trans complexes with FAT4 at cell-cell boundaries; their extracellular domains mediate ligand-receptor binding while the DCHS1 intracellular domain (ICD) and the FAT4 ICD regulate complex internalization, polarized localization, and downstream signaling; the DCHS1-FAT4 axis acts upstream of YAP/TAZ (Hippo pathway effectors) and planar cell polarity to control progenitor proliferation, cell orientation, and differentiation in multiple tissues including the cerebral cortex, kidney, skeleton, and heart valves, with its intracellular scaffold connecting to the septin-actin cytoskeleton via LIX1L and, in a human-specific context, modulating EPHA4-ephrin signaling through an N-glycosylation change."},"narrative":{"mechanistic_narrative":"DCHS1 is a large protocadherin that functions as a ligand-receptor partner of FAT4 to control progenitor proliferation, planar cell polarity, and tissue morphogenesis across many developing organs [PMID:21303848]. Genetic and protein-stabilization data establish a reciprocal DCHS1-FAT4 relationship, with mutation of either gene altering the other's staining and single and double mutants sharing phenotypes [PMID:21303848]. The DCHS1-FAT4 axis acts upstream of the Hippo effector YAP to restrain neural progenitor proliferation and promote differentiation [PMID:24056717], and loss of the axis elevates YAP-TEAD activity, expanding osteoprogenitors and delaying osteoblast differentiation by altering YAP/TAZ-Runx2 complex activity [PMID:31358536]; in other tissues, including renal nephron progenitors and developing vertebrae, DCHS1-FAT4 regulation is YAP/TAZ-independent, indicating context-specific signaling outputs [PMID:26116661, PMID:27381226]. In parallel, DCHS1-FAT4 drives planar cell polarity, controlling polarized cell intercalation and orientation during sternum and skeletal morphogenesis and tangential neuronal migration [PMID:24998526, PMID:27145737]. DCHS1 protein localizes in a polarized manner at the interface between signaling cell populations and is required cell-autonomously for directional FAT4 signaling [PMID:26116666], while the FAT4 intracellular domain controls trans-endocytosis of DCHS1 and actin-dependent boundary accumulation of the complex [PMID:39955614]. The DCHS1 intracellular domain is itself essential: its deletion abolishes polarized localization, perturbs neural cell polarity and proliferation, lowers pYAP1:YAP1 ratios, and produces Van Maldergem syndrome-like craniofacial and skeletal phenotypes [PMID:41972678]. Mechanistically, the DCHS1 cytoplasmic tail links to the septin-actin cytoskeleton through LIX1L and SEPT9 to organize filamentous actin and direct cell-ECM alignment [PMID:35200715]. DCHS1 missense mutations destabilize the protein and cause mitral valve prolapse through valve morphogenesis defects [PMID:26258302].","teleology":[{"year":2011,"claim":"Established that DCHS1 and FAT4 act as a developmentally coupled ligand-receptor pair rather than independent factors, defining the core axis.","evidence":"Single and double knockout mice with reciprocal immunostaining and shared multi-organ phenotypes","pmids":["21303848"],"confidence":"High","gaps":["Did not resolve which downstream effectors transduce the signal","Direct biochemical demonstration of extracellular binding not provided here"]},{"year":2013,"claim":"Placed the DCHS1-FAT4 axis upstream of YAP, connecting protocadherin signaling to the Hippo pathway in neural progenitor control.","evidence":"In utero knockdown in mouse neuroepithelium with Yap concurrent-knockdown epistasis","pmids":["24056717"],"confidence":"High","gaps":["Molecular link between DCHS1-FAT4 and YAP regulation not defined","Whether YAP dependence is universal across tissues unaddressed"]},{"year":2014,"claim":"Distinguished cell-autonomous from extrinsic requirements and showed DCHS1-FAT4 controls planar cell polarity-driven collective migration along defined axes.","evidence":"Conditional and mosaic Dchs1 inactivation with live imaging of facial branchiomotor neuron migration","pmids":["24998526"],"confidence":"High","gaps":["Cytoskeletal effectors of PCP-driven migration not identified","Relationship to Hippo output in this context unclear"]},{"year":2015,"claim":"Demonstrated that DCHS1 missense mutations cause disease through reduced protein stability, linking DCHS1 to human mitral valve prolapse.","evidence":"Zebrafish morpholino rescue, stability assays in patient MVICs, Dchs1+/- mouse valve histology","pmids":["26258302"],"confidence":"High","gaps":["Mechanism linking valve cell patterning defects to morphogenesis not fully resolved","Downstream signaling in valve cells not mapped"]},{"year":2015,"claim":"Showed DCHS1 polarized localization and cell-autonomous requirement mediate directional stroma-to-cap-mesenchyme FAT4 signaling, and that this branch is YAP-independent.","evidence":"Tissue-specific conditional deletions, genetic double mutants, mosaic antibody staining, EM in kidney","pmids":["26116661","26116666"],"confidence":"High","gaps":["YAP-independent effector restraining progenitor self-renewal not identified","Degree of DCHS1/DCHS2 redundancy in other tissues unknown"]},{"year":2016,"claim":"Defined an intrinsic PCP role for DCHS1-FAT4 in mesenchyme shaping skeletal form, and confirmed YAP/TAZ-independent proliferation control in vertebrae.","evidence":"Dchs1/Fat4 knockout mice, cell orientation quantification, Fat4;Yap and Fat4;Taz double mutants","pmids":["27145737","27381226"],"confidence":"High","gaps":["Effector mediating YAP/TAZ-independent proliferation undefined","Link between cell orientation and proliferation control unresolved"]},{"year":2019,"claim":"Connected DCHS1-FAT4 loss to elevated YAP-TEAD activity and altered YAP/TAZ-Runx2 complexes governing osteoblast differentiation.","evidence":"Knockout and conditional Yap/Taz mice, Yap-Tead reporters, Runx2 activity assays, Yap/Taz-Runx2 co-IP","pmids":["31358536"],"confidence":"High","gaps":["How DCHS1-FAT4 mechanistically modulates YAP phosphorylation not shown","Direct DCHS1 involvement in Runx2 complexes not demonstrated"]},{"year":2022,"claim":"Identified a cytoplasmic scaffold connecting DCHS1 to the cytoskeleton, providing a mechanism for cell-ECM alignment.","evidence":"Co-IP/pulldown of DCHS1-LIX1L-SEPT9, actin organization assays in mouse and cell models","pmids":["35200715"],"confidence":"Medium","gaps":["Reciprocal validation and direct binding interfaces not established","Single lab; structural basis of the interaction unknown"]},{"year":2025,"claim":"Resolved how the FAT4 intracellular domain drives trans-endocytosis and actin-dependent boundary accumulation of DCHS1-FAT4 complexes.","evidence":"Quantitative live imaging with ICD deletion constructs and actin polymerization inhibition","pmids":["39955614"],"confidence":"Medium","gaps":["Role of the DCHS1 ICD versus FAT4 ICD in endocytosis not separated here","Molecular machinery of trans-endocytosis not identified"]},{"year":2025,"claim":"Characterized DCHS1 proteolytic cleavage and lineage-restricted cardiac expression, indicating intracellular fragment signaling and heterotypic cell bridging.","evidence":"Dchs1-HA knock-in mouse, western blotting, immunohistochemistry, single-cell transcriptomics","pmids":["40497950"],"confidence":"Medium","gaps":["Function and targets of cleaved C-terminal fragments unknown","Protease responsible for cleavage not identified"]},{"year":2026,"claim":"Established that the DCHS1 intracellular domain is required in vivo for polarized localization, polarity, proliferation control, and YAP regulation, and underlies Van Maldergem-like phenotypes.","evidence":"Dchs1Δ ICD-deletion knock-in mouse with immunohistochemistry, Ki67 assays, pYAP1 quantification","pmids":["41972678"],"confidence":"Medium","gaps":["ICD interactors mediating these effects not enumerated here","Single lab; mechanism linking ICD to pYAP1 changes not detailed"]},{"year":2025,"claim":"Implicated DCHS1 in human-specific neurodevelopmental allocation via an N-glycosylation change and identified EPHA4 as a candidate binding partner.","evidence":"CRISPR editing of hiPSCs, neural organoids, binding partner identification (preprint)","pmids":["40463223"],"confidence":"Low","gaps":["EPHA4 interaction not validated by reciprocal or in vitro binding assay","Preprint; mechanism of EPHA4-ephrin modulation by DCHS1 undefined"]},{"year":null,"claim":"It remains unknown how the DCHS1 ICD and its cleaved fragments biochemically couple to YAP phosphorylation, cytoskeletal scaffolds, and EPHA4 signaling to produce tissue-specific Hippo-dependent versus Hippo-independent outputs.","evidence":"No single study in the corpus integrates the ICD effectors across tissues","pmids":[],"confidence":"Low","gaps":["Direct DCHS1 ICD interactome not mapped","Mechanism switching between YAP-dependent and YAP-independent outputs unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,5]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[9]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,5,10]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,2,6]}],"complexes":[],"partners":["FAT4","LIX1L","SEPT9","EPHA4","DCHS2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96JQ0","full_name":"Protocadherin-16","aliases":["Cadherin-19","Cadherin-25","Fibroblast cadherin-1","Protein dachsous homolog 1"],"length_aa":3298,"mass_kda":346.2,"function":"Calcium-dependent cell-adhesion protein. Mediates functions in neuroprogenitor cell proliferation and differentiation. In the heart, has a critical role for proper morphogenesis of the mitral valve, acting in the regulation of cell migration involved in valve formation (PubMed:26258302)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q96JQ0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DCHS1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DCHS1","total_profiled":1310},"omim":[{"mim_id":"619701","title":"YOON-BELLEN NEURODEVELOPMENTAL SYNDROME; YOBELN","url":"https://www.omim.org/entry/619701"},{"mim_id":"617513","title":"OXOGLUTARATE DEHYDROGENASE-LIKE PROTEIN; OGDHL","url":"https://www.omim.org/entry/617513"},{"mim_id":"615546","title":"VAN MALDERGEM SYNDROME 2; VMLDS2","url":"https://www.omim.org/entry/615546"},{"mim_id":"612411","title":"FAT ATYPICAL CADHERIN 4; FAT4","url":"https://www.omim.org/entry/612411"},{"mim_id":"607829","title":"MITRAL VALVE PROLAPSE 2; MVP2","url":"https://www.omim.org/entry/607829"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DCHS1"},"hgnc":{"alias_symbol":["FIB1","KIAA1773","FLJ11790","CDHR6"],"prev_symbol":["CDH25","PCDH16"]},"alphafold":{"accession":"Q96JQ0","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96JQ0","model_url":"","pae_url":"","plddt_mean":null},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DCHS1","jax_strain_url":"https://www.jax.org/strain/search?query=DCHS1"},"sequence":{"accession":"Q96JQ0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96JQ0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96JQ0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96JQ0"}},"corpus_meta":[{"pmid":"24056717","id":"PMC_24056717","title":"Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24056717","citation_count":215,"is_preprint":false},{"pmid":"21303848","id":"PMC_21303848","title":"Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21303848","citation_count":168,"is_preprint":false},{"pmid":"26258302","id":"PMC_26258302","title":"Mutations in DCHS1 cause mitral valve prolapse.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26258302","citation_count":158,"is_preprint":false},{"pmid":"26116661","id":"PMC_26116661","title":"Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26116661","citation_count":75,"is_preprint":false},{"pmid":"16059920","id":"PMC_16059920","title":"Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16059920","citation_count":74,"is_preprint":false},{"pmid":"26116666","id":"PMC_26116666","title":"Fat4/Dchs1 signaling between stromal and cap mesenchyme cells influences nephrogenesis and ureteric bud branching.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26116666","citation_count":63,"is_preprint":false},{"pmid":"24998526","id":"PMC_24998526","title":"Regulation of neuronal migration by Dchs1-Fat4 planar cell polarity.","date":"2014","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/24998526","citation_count":63,"is_preprint":false},{"pmid":"27145737","id":"PMC_27145737","title":"Dchs1-Fat4 regulation of polarized cell behaviours during skeletal morphogenesis.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27145737","citation_count":46,"is_preprint":false},{"pmid":"31358536","id":"PMC_31358536","title":"Dchs1-Fat4 regulation of osteogenic differentiation in mouse.","date":"2019","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31358536","citation_count":30,"is_preprint":false},{"pmid":"27381226","id":"PMC_27381226","title":"Fat4-Dchs1 signalling controls cell proliferation in developing vertebrae.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27381226","citation_count":28,"is_preprint":false},{"pmid":"29224215","id":"PMC_29224215","title":"Deleterious variants in DCHS1 are prevalent in sporadic cases of mitral valve prolapse.","date":"2017","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29224215","citation_count":13,"is_preprint":false},{"pmid":"35200715","id":"PMC_35200715","title":"DCHS1, Lix1L, and the Septin Cytoskeleton: Molecular and Developmental Etiology of Mitral Valve Prolapse.","date":"2022","source":"Journal of cardiovascular development and disease","url":"https://pubmed.ncbi.nlm.nih.gov/35200715","citation_count":11,"is_preprint":false},{"pmid":"39196305","id":"PMC_39196305","title":"A high-calcium environment induced ectopic calcification of renal interstitial fibroblasts via TFPI-2-DCHS1-ALP/ENPP1 axis to participate in Randall's plaque formation.","date":"2024","source":"Urolithiasis","url":"https://pubmed.ncbi.nlm.nih.gov/39196305","citation_count":5,"is_preprint":false},{"pmid":"37399314","id":"PMC_37399314","title":"Mutation in mitral valve prolapse susceptible gene DCHS1 causes familial mitral annular disjunction.","date":"2024","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37399314","citation_count":4,"is_preprint":false},{"pmid":"32295462","id":"PMC_32295462","title":"DCHS1 DNA copy number loss associated with pediatric urinary tract infection risk.","date":"2020","source":"Innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/32295462","citation_count":3,"is_preprint":false},{"pmid":"39955614","id":"PMC_39955614","title":"Fat4 intracellular domain controls internalization of Fat4/Dchs1 planar polarity membrane complexes.","date":"2025","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/39955614","citation_count":3,"is_preprint":false},{"pmid":"40497950","id":"PMC_40497950","title":"Dynamic Expression and Functional Implications of the Cell Polarity Gene, Dchs1, During Cardiac Development.","date":"2025","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/40497950","citation_count":2,"is_preprint":false},{"pmid":"39938686","id":"PMC_39938686","title":"Connexin 43 dephosphorylation mediates the Dchs1/YAP/TEAD signaling pathway to induce cardiac fibrosis.","date":"2025","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/39938686","citation_count":2,"is_preprint":false},{"pmid":"36434174","id":"PMC_36434174","title":"Neonatal lethality of mouse A/J-7SM consomic strain is caused by an insertion mutation in the Dchs1 gene.","date":"2022","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/36434174","citation_count":1,"is_preprint":false},{"pmid":"40463223","id":"PMC_40463223","title":"DCHS1 Modulates Forebrain Proportions in Modern Humans via a Glycosylation Change.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40463223","citation_count":1,"is_preprint":false},{"pmid":"41972678","id":"PMC_41972678","title":"Loss of the DCHS1 Intracellular Domain Expands Neurogenic Proliferation and Generates Van Maldergem-like Neurodevelopmental Defects.","date":"2026","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/41972678","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.07.10.602948","title":"Neuronal Hyperactivity in Neurons Derived from Individuals with Grey Matter Heterotopia","date":"2024-07-10","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.10.602948","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13128,"output_tokens":4153,"usd":0.05084,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12118,"output_tokens":3893,"usd":0.078957,"stage2_stop_reason":"end_turn"},"total_usd":0.129797,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"DCHS1 and FAT4 function as a ligand-receptor pair during mammalian development; mutation of either gene increases protein staining for the other, and single and double mutants share similar phenotypes across multiple organs, establishing their epistatic relationship.\",\n      \"method\": \"Gene-targeted mouse mutants (Dchs1 and Fat4 single and double knockouts), immunostaining, phenotypic analysis across multiple organs\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic interaction confirmed by double mutants and protein-level stabilization; replicated across multiple organs and tissues in a single rigorous study\",\n      \"pmids\": [\"21303848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DCHS1 and FAT4 act upstream of YAP (a transcriptional effector of the Hippo signaling pathway) to regulate neural progenitor proliferation and differentiation; concurrent knockdown of Yap countered the increased progenitor numbers caused by Dchs1 or Fat4 knockdown in mouse neuroepithelium.\",\n      \"method\": \"In utero knockdown in mouse embryonic neuroepithelium, genetic epistasis (Yap concurrent knockdown), histological analysis of cortical layering\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with Yap rescue, replicated across DCHS1 and FAT4, multiple orthogonal methods\",\n      \"pmids\": [\"24056717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DCHS1 and FAT4 are expressed in complementary gradients and are required cell-autonomously within facial branchiomotor (FBM) neurons and extrinsically within the neuroepithelium for collective tangential neuronal migration and planar cell polarity; Fat-PCP and Fz-PCP regulate FBM neuron migration along orthogonal axes.\",\n      \"method\": \"Mouse conditional knockouts, mosaic inactivation of Dchs1, live imaging of neuronal migration, planar cell polarity analysis\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic mosaic and conditional KO experiments, multiple orthogonal methods, cell-autonomous and non-autonomous roles distinguished\",\n      \"pmids\": [\"24998526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DCHS1 missense mutations reduce protein stability in zebrafish, cultured cells, and human mitral valve interstitial cells (MVICs); DCHS1-deficient MVICs show altered migration and cellular patterning, and Dchs1+/- mice exhibit mitral valve prolapse traceable to developmental valve morphogenesis errors.\",\n      \"method\": \"Zebrafish morpholino knockdown with mRNA rescue, protein stability assays in cultured cells and patient-derived MVICs, Dchs1+/- mouse histology, cell migration assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (zebrafish rescue, patient cells, mouse model), functional rescue demonstrates causality of mutation\",\n      \"pmids\": [\"26258302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FAT4 acts non-autonomously in the renal stroma to bind DCHS1/DCHS2 in the cap mesenchyme and restrict nephron progenitor self-renewal; FAT4-dependent regulation of cap mesenchyme is independent of YAP, and DCHS1 and its paralogue DCHS2 function in a partially redundant manner.\",\n      \"method\": \"Tissue-specific conditional deletions (stromal Fat4 KO), genetic double mutants (Six2-/-;Fat4-/-), electron microscopy, gene expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific KO, double-mutant epistasis, multiple orthogonal methods in one study\",\n      \"pmids\": [\"26116661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DCHS1 protein localizes in a polarized manner within cap mesenchyme cells, accumulating at the interface with stromal cells, and is required specifically within cap mesenchyme for Fat4-dependent stroma-to-cap mesenchyme signaling during kidney development.\",\n      \"method\": \"Antibody staining of genetic mosaics, conditional Dchs1 KO, immunolocalization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mosaic analysis, conditional KO, direct polarized protein localization with functional consequence established\",\n      \"pmids\": [\"26116666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The Dchs1-Fat4 planar cell polarity pathway controls cell orientation in pre-chondrogenic mesenchyme to define skeletal shape; loss of Dchs1 or Fat4 disrupts polarized cell intercalation driving sternum morphogenesis, establishing intrinsic PCP function of Dchs1-Fat4 in mesenchyme.\",\n      \"method\": \"Dchs1 and Fat4 mouse knockouts, cell orientation analysis, histological and morphometric analysis of sternum\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse phenotype with quantified cell polarity analysis, single lab but multiple methods\",\n      \"pmids\": [\"27145737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Fat4-Dchs1 regulates cell proliferation in developing vertebrae independently of Yap and Taz; Fat4 and Dchs1 mutant mice show decreased proliferation in early sclerotome, and Fat4;Yap and Fat4;Taz double mutants do not rescue the vertebral phenotype.\",\n      \"method\": \"Fat4 and Dchs1 knockout mice, Fat4;Yap and Fat4;Taz double mutants, proliferation assays, Ctgf expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with Yap and Taz double mutants, multiple orthogonal methods, negative result for Hippo pathway involvement rigorously established\",\n      \"pmids\": [\"27381226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Dchs1-Fat4 signaling is required for osteoblast differentiation; loss of Dchs1-Fat4 increases Yap-Tead activity and osteoprogenitor proliferation while delaying osteoblast differentiation; Yap and Taz differentially regulate Runx2 transcriptional activity, and Yap-Runx2 and Taz-Runx2 complex activities are altered in Dchs1/Fat4 mutants.\",\n      \"method\": \"Dchs1 and Fat4 mouse knockouts, Yap/Taz conditional knockouts, Yap-Tead reporter assays, Runx2 transcriptional activity assays, co-immunoprecipitation of Yap/Taz-Runx2 complexes\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — Co-IP for complexes, reporter assays, conditional KO epistasis, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"31358536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"DCHS1 interacts with cytoplasmic protein LIX1L (Lix1-Like) and SEPT9; this DCHS1-LIX1L-SEPT9 axis promotes filamentous actin organization to direct cell-ECM alignment and valve tissue shape.\",\n      \"method\": \"Biochemical co-immunoprecipitation/pulldown, mouse and cell culture models, actin organization assays\",\n      \"journal\": \"Journal of cardiovascular development and disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP for novel protein interactions, functional phenotype in cells and mouse, single lab\",\n      \"pmids\": [\"35200715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The intracellular domain (ICD) of Fat4 controls trans-endocytosis of Dchs1 into Fat4 cells and boundary accumulation of Fat4/Dchs1 complexes; removing the Fat4 ICD reduces both Dchs1 trans-endocytosis and boundary accumulation but does not affect diffusion of complexes at the boundary; actin polymerization is required for boundary accumulation of Fat4/Dchs1 complexes.\",\n      \"method\": \"Quantitative live imaging, ICD deletion constructs, actin polymerization inhibition\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative live imaging with deletion mutants, single lab, single study\",\n      \"pmids\": [\"39955614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DCHS1 undergoes proteolytic cleavage generating intracellular C-terminal fragments; cardiac DCHS1 expression is restricted to non-cardiomyocyte lineages, displays dynamic subcellular localization during development, and DCHS1-positive non-myocyte cells form polarized extensions bridging endothelial and non-myocyte cells, suggesting direct heterotypic and homotypic interactions.\",\n      \"method\": \"Dchs1-HA knock-in mouse, immunohistochemistry, western blotting, single-cell transcriptomics\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — direct localization with HA knock-in model, western blot evidence for cleavage, single lab multiple methods\",\n      \"pmids\": [\"40497950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Phosphorylation of Cx43 at serine 282 increases DCHS1 gene expression, which activates YAP phosphorylation and inhibits the YAP/TEAD signaling pathway to suppress cardiac fibrosis.\",\n      \"method\": \"Lentiviral overexpression and mutation of Cx43 S282 in cardiac myofibroblasts, mRNA sequencing/GSEA, in vivo adenoviral injection, Hippo pathway reporter assays\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, DCHS1 as intermediate in Cx43-YAP axis supported mainly by expression changes and pathway inference, limited direct mechanistic validation of DCHS1's role\",\n      \"pmids\": [\"39938686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A modern human-specific substitution in DCHS1 disrupts an N-glycosylation site; restoring the ancestral (Neanderthal) DCHS1 variant in human iPSC-derived neural organoids expands striatal progenitors at the expense of neocortex. EPHA4 (ephrin receptor) was identified as a binding partner of DCHS1, and DCHS1 modulates EPHA4-ephrin signaling.\",\n      \"method\": \"CRISPR/Cas9 editing of hiPSCs, neural organoids, binding partner identification (method not fully specified in abstract)\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, binding partner not validated by reciprocal or in vitro assay as described in abstract, single lab\",\n      \"pmids\": [\"40463223\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Deletion of the DCHS1 intracellular domain (ICD) in mice results in loss of polarized DCHS1 localization in the subventricular zone, altered neural cell polarization, increased Ki67+ proliferation with greater Ki67-neuronal co-localization, and reduced pYAP1:YAP1 ratios in neonatal brains; craniofacial and skeletal phenotypes resembling Van Maldergem Syndrome are also observed.\",\n      \"method\": \"Dchs1Δ (ICD deletion) knock-in mouse, immunohistochemistry, western blotting, Ki67 proliferation assays, pYAP1 quantification\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ICD deletion KI mouse with multiple phenotypic readouts and Hippo pathway quantification, single lab\",\n      \"pmids\": [\"41972678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In DCHS1 patient-derived neurons (from individuals with periventricular heterotopia), patch-clamp recordings revealed a decreased spike threshold due to increased somatic voltage-gated sodium channels; morphological rescue was observed by re-expression of wild-type DCHS1.\",\n      \"method\": \"Human cerebral organoids from FAT4/DCHS1 mutation carriers, silicon probe recordings, patch-clamp electrophysiology, morphological reconstruction, immunostaining, transcriptome/proteome analysis, DCHS1 rescue experiment\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patch-clamp with rescue experiment in organoids, single lab, preprint\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TFPI-2 promotes high-calcium-induced calcification of renal interstitial fibroblasts via upregulation of DCHS1, which in turn disturbs the balance of ENPP1/ALP activities; DCHS1 knockdown suppressed TFPI-2-enhanced calcification.\",\n      \"method\": \"Transcriptome sequencing, TFPI-2 knockdown/overexpression, DCHS1 knockdown in human renal interstitial fibroblasts, Alizarin Red staining, ENPP1/ALP activity assays\",\n      \"journal\": \"Urolithiasis\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, downstream pathway placement of DCHS1 in a non-canonical context based on knockdown only\",\n      \"pmids\": [\"39196305\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DCHS1 is a large transmembrane protocadherin that forms heterophilic trans complexes with FAT4 at cell-cell boundaries; their extracellular domains mediate ligand-receptor binding while the DCHS1 intracellular domain (ICD) and the FAT4 ICD regulate complex internalization, polarized localization, and downstream signaling; the DCHS1-FAT4 axis acts upstream of YAP/TAZ (Hippo pathway effectors) and planar cell polarity to control progenitor proliferation, cell orientation, and differentiation in multiple tissues including the cerebral cortex, kidney, skeleton, and heart valves, with its intracellular scaffold connecting to the septin-actin cytoskeleton via LIX1L and, in a human-specific context, modulating EPHA4-ephrin signaling through an N-glycosylation change.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DCHS1 is a large protocadherin that functions as a ligand-receptor partner of FAT4 to control progenitor proliferation, planar cell polarity, and tissue morphogenesis across many developing organs [#0]. Genetic and protein-stabilization data establish a reciprocal DCHS1-FAT4 relationship, with mutation of either gene altering the other's staining and single and double mutants sharing phenotypes [#0]. The DCHS1-FAT4 axis acts upstream of the Hippo effector YAP to restrain neural progenitor proliferation and promote differentiation [#1], and loss of the axis elevates YAP-TEAD activity, expanding osteoprogenitors and delaying osteoblast differentiation by altering YAP/TAZ-Runx2 complex activity [#8]; in other tissues, including renal nephron progenitors and developing vertebrae, DCHS1-FAT4 regulation is YAP/TAZ-independent, indicating context-specific signaling outputs [#4, #7]. In parallel, DCHS1-FAT4 drives planar cell polarity, controlling polarized cell intercalation and orientation during sternum and skeletal morphogenesis and tangential neuronal migration [#2, #6]. DCHS1 protein localizes in a polarized manner at the interface between signaling cell populations and is required cell-autonomously for directional FAT4 signaling [#5], while the FAT4 intracellular domain controls trans-endocytosis of DCHS1 and actin-dependent boundary accumulation of the complex [#10]. The DCHS1 intracellular domain is itself essential: its deletion abolishes polarized localization, perturbs neural cell polarity and proliferation, lowers pYAP1:YAP1 ratios, and produces Van Maldergem syndrome-like craniofacial and skeletal phenotypes [#14]. Mechanistically, the DCHS1 cytoplasmic tail links to the septin-actin cytoskeleton through LIX1L and SEPT9 to organize filamentous actin and direct cell-ECM alignment [#9]. DCHS1 missense mutations destabilize the protein and cause mitral valve prolapse through valve morphogenesis defects [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Established that DCHS1 and FAT4 act as a developmentally coupled ligand-receptor pair rather than independent factors, defining the core axis.\",\n      \"evidence\": \"Single and double knockout mice with reciprocal immunostaining and shared multi-organ phenotypes\",\n      \"pmids\": [\"21303848\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which downstream effectors transduce the signal\", \"Direct biochemical demonstration of extracellular binding not provided here\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Placed the DCHS1-FAT4 axis upstream of YAP, connecting protocadherin signaling to the Hippo pathway in neural progenitor control.\",\n      \"evidence\": \"In utero knockdown in mouse neuroepithelium with Yap concurrent-knockdown epistasis\",\n      \"pmids\": [\"24056717\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between DCHS1-FAT4 and YAP regulation not defined\", \"Whether YAP dependence is universal across tissues unaddressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Distinguished cell-autonomous from extrinsic requirements and showed DCHS1-FAT4 controls planar cell polarity-driven collective migration along defined axes.\",\n      \"evidence\": \"Conditional and mosaic Dchs1 inactivation with live imaging of facial branchiomotor neuron migration\",\n      \"pmids\": [\"24998526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cytoskeletal effectors of PCP-driven migration not identified\", \"Relationship to Hippo output in this context unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated that DCHS1 missense mutations cause disease through reduced protein stability, linking DCHS1 to human mitral valve prolapse.\",\n      \"evidence\": \"Zebrafish morpholino rescue, stability assays in patient MVICs, Dchs1+/- mouse valve histology\",\n      \"pmids\": [\"26258302\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking valve cell patterning defects to morphogenesis not fully resolved\", \"Downstream signaling in valve cells not mapped\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed DCHS1 polarized localization and cell-autonomous requirement mediate directional stroma-to-cap-mesenchyme FAT4 signaling, and that this branch is YAP-independent.\",\n      \"evidence\": \"Tissue-specific conditional deletions, genetic double mutants, mosaic antibody staining, EM in kidney\",\n      \"pmids\": [\"26116661\", \"26116666\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"YAP-independent effector restraining progenitor self-renewal not identified\", \"Degree of DCHS1/DCHS2 redundancy in other tissues unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined an intrinsic PCP role for DCHS1-FAT4 in mesenchyme shaping skeletal form, and confirmed YAP/TAZ-independent proliferation control in vertebrae.\",\n      \"evidence\": \"Dchs1/Fat4 knockout mice, cell orientation quantification, Fat4;Yap and Fat4;Taz double mutants\",\n      \"pmids\": [\"27145737\", \"27381226\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Effector mediating YAP/TAZ-independent proliferation undefined\", \"Link between cell orientation and proliferation control unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Connected DCHS1-FAT4 loss to elevated YAP-TEAD activity and altered YAP/TAZ-Runx2 complexes governing osteoblast differentiation.\",\n      \"evidence\": \"Knockout and conditional Yap/Taz mice, Yap-Tead reporters, Runx2 activity assays, Yap/Taz-Runx2 co-IP\",\n      \"pmids\": [\"31358536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How DCHS1-FAT4 mechanistically modulates YAP phosphorylation not shown\", \"Direct DCHS1 involvement in Runx2 complexes not demonstrated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified a cytoplasmic scaffold connecting DCHS1 to the cytoskeleton, providing a mechanism for cell-ECM alignment.\",\n      \"evidence\": \"Co-IP/pulldown of DCHS1-LIX1L-SEPT9, actin organization assays in mouse and cell models\",\n      \"pmids\": [\"35200715\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reciprocal validation and direct binding interfaces not established\", \"Single lab; structural basis of the interaction unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Resolved how the FAT4 intracellular domain drives trans-endocytosis and actin-dependent boundary accumulation of DCHS1-FAT4 complexes.\",\n      \"evidence\": \"Quantitative live imaging with ICD deletion constructs and actin polymerization inhibition\",\n      \"pmids\": [\"39955614\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Role of the DCHS1 ICD versus FAT4 ICD in endocytosis not separated here\", \"Molecular machinery of trans-endocytosis not identified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Characterized DCHS1 proteolytic cleavage and lineage-restricted cardiac expression, indicating intracellular fragment signaling and heterotypic cell bridging.\",\n      \"evidence\": \"Dchs1-HA knock-in mouse, western blotting, immunohistochemistry, single-cell transcriptomics\",\n      \"pmids\": [\"40497950\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Function and targets of cleaved C-terminal fragments unknown\", \"Protease responsible for cleavage not identified\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Established that the DCHS1 intracellular domain is required in vivo for polarized localization, polarity, proliferation control, and YAP regulation, and underlies Van Maldergem-like phenotypes.\",\n      \"evidence\": \"Dchs1\\u0394 ICD-deletion knock-in mouse with immunohistochemistry, Ki67 assays, pYAP1 quantification\",\n      \"pmids\": [\"41972678\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ICD interactors mediating these effects not enumerated here\", \"Single lab; mechanism linking ICD to pYAP1 changes not detailed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Implicated DCHS1 in human-specific neurodevelopmental allocation via an N-glycosylation change and identified EPHA4 as a candidate binding partner.\",\n      \"evidence\": \"CRISPR editing of hiPSCs, neural organoids, binding partner identification (preprint)\",\n      \"pmids\": [\"40463223\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"EPHA4 interaction not validated by reciprocal or in vitro binding assay\", \"Preprint; mechanism of EPHA4-ephrin modulation by DCHS1 undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how the DCHS1 ICD and its cleaved fragments biochemically couple to YAP phosphorylation, cytoskeletal scaffolds, and EPHA4 signaling to produce tissue-specific Hippo-dependent versus Hippo-independent outputs.\",\n      \"evidence\": \"No single study in the corpus integrates the ICD effectors across tissues\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Direct DCHS1 ICD interactome not mapped\", \"Mechanism switching between YAP-dependent and YAP-independent outputs unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 5, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 2, 6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"FAT4\", \"LIX1L\", \"SEPT9\", \"EPHA4\", \"DCHS2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}